Compounds > quinidine
Page last updated: 2024-08-17

quinidine and ximelagatran

quinidine has been researched along with ximelagatran in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Ekins, S; Williams, AJ; Xu, JJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Dorani, H; Eriksson, UG; Fritsch, H; Hoffmann, KJ; Karlsson, J; Olsson, L; Sarich, TC; Schützer, KM; Wall, U1

Reviews

1 review(s) available for quinidine and ximelagatran

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

3 other study(ies) available for quinidine and ximelagatran

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Influence of erythromycin on the pharmacokinetics of ximelagatran may involve inhibition of P-glycoprotein-mediated excretion.
    Drug metabolism and disposition: the biological fate of chemicals, 2006, Volume: 34, Issue:5

    Topics: Adult; Animals; Anti-Bacterial Agents; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azetidines; Benzylamines; Bile; Biological Transport, Active; Caco-2 Cells; Calcium Channel Blockers; Cell Line; Dogs; Dose-Response Relationship, Drug; Drug Interactions; Erythromycin; Female; Humans; In Vitro Techniques; Male; Partial Thromboplastin Time; Quinidine; Rats; Rats, Sprague-Dawley; Verapamil

2006